SEC Form 4 · accession 0001209191-17-066234
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lauren Bullaro Riker
Officer — Vice President, Finance
Period of report
Dec 15, 2017
Accepted (ET)
Dec 18, 2017 · 7:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2017 | S | 340 | $43.70 | D | 10,442 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 719 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017.